Herbst RS - Search Results

1

Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease.

Zinner RG, Glisson BS, Fossella FV, Pisters KM, Kies MS, Lee PM, Massarelli E, Sabloff B, Fritsche HA Jr, Ro JY, Ordonez NG, Tran HT, Yang Y, Smith TL, Mass RD, Herbst RS. Zinner RG, et al. Among authors: herbst rs. Lung Cancer. 2004 Apr;44(1):99-110. doi: 10.1016/j.lungcan.2003.09.026. Lung Cancer. 2004. PMID: 15013588 Clinical Trial.

2

Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancer.

Herbst RS, Lilenbaum R. Herbst RS, et al. Semin Oncol. 1999 Oct;26(5 Suppl 16):67-70; discussion 71-2. Semin Oncol. 1999. PMID: 10585011 Review.

3

Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.

Herbst RS, Yano S, Kuniyasu H, Khuri FR, Bucana CD, Guo F, Liu D, Kemp B, Lee JJ, Hong WK, Fidler IJ. Herbst RS, et al. Clin Cancer Res. 2000 Mar;6(3):790-7. Clin Cancer Res. 2000. PMID: 10741698

4

9:00-9:15. Antiangiogenic Treatment with Endostatin Results in Uncoupling of Blood Flow and Glucose Metabolism in Human Tumors.

Mullani N, Herbst R, Abbruzzese J, Charnsangavej C, Kim E, Tran H, Barron B, Lamki L, Gould K. Mullani N, et al. Clin Positron Imaging. 2000 Jul;3(4):151. doi: 10.1016/s1095-0397(00)00063-7. Clin Positron Imaging. 2000. PMID: 11150754

5

9:30-9:45. First Pass FDG Measured Blood Flow in Tumors: A Comparison with O-15 Labeled Water Measured Blood Flow.

Mullani N, Herbst R, Abbruzzese J, Barron B, Lamki L, Charnsangavej C, Kim E, Tran H, Jiwani A, Gould K. Mullani N, et al. Clin Positron Imaging. 2000 Jul;3(4):153. doi: 10.1016/s1095-0397(00)00065-0. Clin Positron Imaging. 2000. PMID: 11150756

6

Clinical studies of angiogenesis inhibitors: the University of Texas MD Anderson Center Trial of Human Endostatin.

Herbst RS, Lee AT, Tran HT, Abbruzzese JL. Herbst RS, et al. Curr Oncol Rep. 2001 Mar;3(2):131-40. doi: 10.1007/s11912-001-0013-8. Curr Oncol Rep. 2001. PMID: 11177745

7

Lung cancer in patients under age 40.

Skarin AT, Herbst RS, Leong TL, Bailey A, Sugarbaker D. Skarin AT, et al. Among authors: herbst rs. Lung Cancer. 2001 Jun;32(3):255-64. doi: 10.1016/s0169-5002(00)00233-6. Lung Cancer. 2001. PMID: 11390007

8

Emerging therapies in non-small-cell lung cancer.

Khuri FR, Herbst RS, Fossella FV. Khuri FR, et al. Among authors: herbst rs. Ann Oncol. 2001 Jun;12(6):739-44. doi: 10.1023/a:1011197500223. Ann Oncol. 2001. PMID: 11484947 Free article. Review.

9

Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.

Herbst RS, Lynch C, Vasconcelles M, Teicher BA, Strauss G, Elias A, Anderson I, Zacarola P, Dang NH, Leong T, Salgia R, Skarin AT. Herbst RS, et al. Cancer Chemother Pharmacol. 2001 Aug;48(2):151-9. doi: 10.1007/s002800100282. Cancer Chemother Pharmacol. 2001. PMID: 11561781 Clinical Trial.

10

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer.

Kim ES, Lu C, Khuri FR, Tonda M, Glisson BS, Liu D, Jung M, Hong WK, Herbst RS. Kim ES, et al. Among authors: herbst rs. Lung Cancer. 2001 Dec;34(3):427-32. doi: 10.1016/s0169-5002(01)00278-1. Lung Cancer. 2001. PMID: 11714540 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters